Corteva (NYSE:CTVA) CEO Buys $300,315.60 in Stock

Corteva, Inc. (NYSE:CTVA – Get Free Report) CEO Luther Iv Kissam acquired 32,292 shares of Corteva stock in a transaction on Friday, November 13th. The shares were bought at an average cost of $9.30 per share, with a total value of $300,315.60. Following the completion of the transaction, the chief executive officer owned 185,379 shares of the company’s stock, valued at approximately $1,724,024.70. This trade represents a 21.09% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Corteva Price Performance

Shares of CTVA opened at $8.37 on Thursday. The firm has a market capitalization of $5.58 billion, a PE ratio of 2.22, a PEG ratio of 1.26 and a beta of 0.58. The company’s 50-day moving average is $32.58 and its 200-day moving average is $68.60. Corteva, Inc. has a fifty-two week low of $8.35 and a fifty-two week high of $90.97. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.56 and a quick ratio of 1.08.

Corteva Cuts Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Tuesday, December 1st will be paid a $0.05 dividend. This is a decrease from Corteva’s previous quarterly dividend of $0.18. The ex-dividend date is Tuesday, December 1st. This represents a $0.20 dividend on an annualized basis and a yield of 2.4%. Corteva’s dividend payout ratio (DPR) is currently 37.89%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on CTVA shares. KeyCorp reduced their price objective on Corteva from $17.00 to $14.00 and set an “overweight” rating for the company in a report on Monday. Wall Street Zen downgraded Corteva from a “hold” rating to a “sell” rating in a research note on Saturday, November 14th. Argus reaffirmed a “buy” rating and issued a $91.00 price objective on shares of Corteva in a report on Friday, September 18th. Citigroup dropped their target price on Corteva from $13.65 to $10.30 and set a “neutral” rating for the company in a report on Friday, November 13th. Finally, The Goldman Sachs Group reissued a “buy” rating and issued a $20.00 target price on shares of Corteva in a research report on Thursday, October 8th. Fifteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $52.47.

Read Our Latest Stock Report on CTVA

Top Corteva Stories

These are some of the CTVA stories that stood out recently:

Institutional Trading of Corteva

Large investors have recently modified their holdings of the stock. BlackRock Inc. bought a new stake in Corteva during the second quarter worth about $4,560,180,000. Wellington Management Group LLP grew its stake in Corteva by 941.7% during the second quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company’s stock worth $644,720,000 after buying an additional 6,881,875 shares in the last quarter. Royal Bank of Canada increased its holdings in Corteva by 202.1% in the 1st quarter. Royal Bank of Canada now owns 7,458,624 shares of the company’s stock valued at $624,362,000 after buying an additional 4,989,371 shares during the period. Jupiter Topco LLC bought a new position in Corteva in the 2nd quarter valued at about $544,246,000. Finally, Bank of America Corp DE acquired a new position in shares of Corteva in the 2nd quarter valued at approximately $484,927,000. 81.54% of the stock is owned by institutional investors and hedge funds.

Corteva Company Profile

(Get Free Report)

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.

Read More

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.